The in vitro toxicology of Swedish snus

References

• Ames BN, Durston WE, Yamasaki E, Lee FD. (1973). Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70:2281–2285.
   PubMed Web of Science ®Google Scholar
• Ames BN, Mccann J, Yamasaki E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347–364.
   PubMed Web of Science ®Google Scholar
• Andreoli C, Gigante D, Nunziata A. (2003). A review of in vitro methods to assess the biological activity of tobacco smoke with the aim of reducing the toxicity of smoke. Toxicol In Vitro 17:587–594.
   PubMed Web of Science ®Google Scholar
• Babich H, Borenfreund E. (1990). Cytotoxic effects of food additives and pharmaceuticals on cells in culture as determined with the neutral red assay. J Pharm Sci 79:592–594.
   PubMed Web of Science ®Google Scholar
• Borenfreund E, Puerner JA. (1985). Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24:119–124.
   PubMed Web of Science ®Google Scholar
• Borgerding M, Bodnar J, Swauger J. (2009). The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007. Winston-Salem: R.J. Reynolds Tobacco Co.
   Google Scholar
• Cariello NF, Piegorsch WW. (1996). The Ames test: the two-fold rule revisited. Mutat Res 369:23–31.
   PubMed Web of Science ®Google Scholar
• Clive D, Bolcsfoldi G, Clements J, Cole J, Homna M, Majeska J, Moore M, Müller L, Myhr B, Oberly T. (1995). Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, May 7, 1994. Environ Mol Mutagen 25:165–168.
   PubMed Web of Science ®Google Scholar
• Clive D, Flamm WG, Machesko MR, Bernheim NJ. (1972). A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat Res 16:77–87.
   PubMed Web of Science ®Google Scholar
• Colilla SA. (2010). An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regul Toxicol Pharmacol 56:197–211.
   PubMed Web of Science ®Google Scholar
• DeMarini DM. (2004). Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 567:447–474.
   PubMed Web of Science ®Google Scholar
• DeMarini DM, Gudi R, Szkudlinska A, Rao M, Recio L, Kehl M, Kirby PE, Polzin G, Richter PA. (2008). Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates. Mutat Res 650:15–29.
   PubMed Web of Science ®Google Scholar
• Fagerstrom K, Rutqvist LE, Hughes JR. (2012). Snus as a smoking cessation aid: a randomized placebo-controlled trial. Nicotine Tob Res 14:306–312.
   PubMed Web of Science ®Google Scholar
• Gaworski CL, Oldham MJ, Coggins CR. (2010). Toxicological considerations on the use of propylene glycol as a humectant in cigarettes. Toxicology 269:54–66.
   PubMed Web of Science ®Google Scholar
• IARC. (2004). Tobacco Smoke and Involuntary Smoking. IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer, 1191–1413.
   Google Scholar
• IARC. (2007). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 89. Smokeless Tobacco and some tobacco-specific N-Nitrosamines. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer.
   Google Scholar
• Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, Wallström M, Hirsch JM, Nilsen R. (1998). The Swedish snus and the Sudanese toombak: are they different? Oral Oncol 34:558–566.
   PubMed Web of Science ®Google Scholar
• Jansson T, Romert L, Magnusson J, Jenssen D. (1991). Genotoxicity testing of extracts of a Swedish moist oral snuff. Mutat Res 261:101–115.
   PubMed Web of Science ®Google Scholar
• Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG. (2009). Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol Biomarkers Prev 18:3263–3304.
   PubMed Web of Science ®Google Scholar
• Joksic G, Spasojevic-Tišma V, Antic R, Nilsson R, Rutqvist LE. (2011). Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation. Harm Reduct J 8:25.
   PubMed Web of Science ®Google Scholar
• King AV, Jones PA. (2003). In-house assessment of a modified in vitro cytotoxicity assay for higher throughput estimation of acute toxicity. Toxicol In Vitro 17:717–722.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Aardema M, Henderson L, Müller L. (2005). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. Mutat Res 584:1–256.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Reeve L, Gatehouse D, Vanparys P. (2011). A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res 721:27–73.
   PubMed Web of Science ®Google Scholar
• Lee PN. (2011). Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 59:197–214.
   PubMed Web of Science ®Google Scholar
• Lee PN, Hamling J. (2009). Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med 7:36.
   PubMed Web of Science ®Google Scholar
• Lorge E, Thybaud V, Aardema MJ, Oliver J, Wakata A, Lorenzon G, Marzin D. (2006). SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutat Res 607:13–36.
   PubMed Web of Science ®Google Scholar
• Lund KE, Scheffels J, McNeill A. (2011). The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies. Addiction 106:162–167.
   PubMed Web of Science ®Google Scholar
• McCann J, Choi E, Yamasaki E, Ames BN. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc Natl Acad Sci USA 72:5135–5139.
   PubMed Web of Science ®Google Scholar
• Moore MM, Honma M, Clements J, Bolcsfoldi G, Burlinson B, Cifone M, Clarke J, Delongchamp R, Durward R, Fellows M, Gollapudi B, Hou S, Jenkinson P, Lloyd M, Majeska J, Myhr B, O’Donovan M, Omori T, Riach C, San R, Stankowski LF Jr, Thakur AK, Van Goethem F, Wakuri S, Yoshimura I. (2006). Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing–Aberdeen, Scotland, 2003–Assay acceptance criteria, positive controls, and data evaluation. Environ Mol Mutagen 47:1–5.
   PubMed Web of Science ®Google Scholar
• Nemes Z, Dietz R, Lüth JB, Gomba S, Hackenthal E, Gross F. (1979). The pharmacological relevance of vital staining with neutral red. Experientia 35:1475–1476.
   PubMedGoogle Scholar
• North Carolina Agricultural Research Service. (2006). Smokeless Tobacco Research Products. Raleigh, NC: North Carolina State University.
   Google Scholar
• OECD. (1997a). No. 471. Bacterial reverse mutation test. OECD guideline for testing of chemicals. Paris, France.
   Google Scholar
• OECD. (1997b). No. 474. Mammalian erythrocyte micronucleus test. OECD guideline for testing of chemicals. Paris, France.
   Google Scholar
• OECD. (1997c). No. 476. In Vitro mammalian cell gene mutation test. OECD guideline for the testing of chemicals. Paris, France.
   Google Scholar
• OECD. (2007). Draft proposal for a new Guideline 487: In Vitro mammalian cell micronucleus test (MNvit). OECD guideline for the testing of chemicals. Paris, France.
   Google Scholar
• Okuwa K, Tanaka M, Fukano Y, Nara H, Nishijima Y, Nishino T. (2010). In vitro micronucleus assay for cigarette smoke using a whole smoke exposure system: a comparison of smoking regimens. Exp Toxicol Pathol 62:433–440.
   PubMed Web of Science ®Google Scholar
• Osterdahl BG, Jansson C, Paccou A. (2004). Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. J Agric Food Chem 52:5085–5088.
   PubMed Web of Science ®Google Scholar
• Patskan GJ, Podraza KF, Meurrens K, Coggins CR, Friedrichs B, Gerstenberg B, Gomm W, Schnell P, Stabbert R, Veltel D, Weber S, Terpstra P. (2008). Toxicological comparisons of three styles of a commercial U.S. cigarette (Marlboro with the 1R4F reference cigarette. Inhal Toxicol 20:695–721.
   PubMed Web of Science ®Google Scholar
• Pfuhler S, Albertini S, Fautz R, Herbold B, Madle S, Utesch D, Poth A; Gesellschaft fuer Umwelt-Mutationsforschung. (2007). Genetic toxicity assessment: employing the best science for human safety evaluation part IV: Recommendation of a working group of the Gesellschaft fuer Umwelt-Mutationsforschung (GUM) for a simple and straightforward approach to genotoxicity testing. Toxicol Sci 97:237–240.
   PubMed Web of Science ®Google Scholar
• Rickert WS, Wright WG, Trivedi AH, Momin RA, Lauterbach JH. (2007). A comparative study of the mutagenicity of various types of tobacco products. Regul Toxicol Pharmacol 48:320–330.
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Curvall M, Hassler T, Ringberger T, Wahlberg I. (2011). Swedish snus and the GothiaTek® standard. Harm Reduct J 8:11.
   PubMed Web of Science ®Google Scholar
• Schramke H, Meisgen TJ, Tewes FJ, Gomm W, Roemer E. (2006). The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 227:193–210.
   PubMed Web of Science ®Google Scholar
• Scientific Committee on Emerging and Newly Identified Health Risks. (2008). Health Effects of Smokeless Tobacco Products. Brussels, Belgium: Directorate-General, Health and Consumer Protection, European Commission.
   Google Scholar
• Stanfill SB, Connolly GN, Zhang L, Jia LT, Henningfield JE, Richter P, Lawler TS, Ayo-Yusuf OA, Ashley DL, Watson CH. (2011). Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control 20:e2.
   Web of Science ®Google Scholar
• Tambwekar KR, Kakariya RB, Garg S. (2003). A validated high performance liquid chromatographic method for analysis of nicotine in pure form and from formulations. J Pharm Biomed Anal 32:441–450.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. (2004). The Health Consequences of Smoking. A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
   Google Scholar
• Werley MS, Freelin SA, Wrenn SE, Gerstenberg B, Roemer E, Schramke H, Van Miert E, Vanscheeuwijck P, Weber S, Coggins CR. (2008). Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K. Regul Toxicol Pharmacol 52:122–139.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2008). WHO study group on tobacco product regulation: report on the scientific basis of tobacco product regulation: third report of a WHO study group. WHO technical report series: no. 955. Geneva, Switzerland: World Health Organization.
   Google Scholar